GREENNANOBONE FIRST PROGRESS MEETING
This week, our regulatory experts, Maria Castellà and Alejandro Ballester, participated in the first consortium meeting of
July 6, 2026
This week, our regulatory experts, Maria Castellà and Alejandro Ballester, participated in the first consortium meeting of
The objective of this project is to create a siRNA-combined advanced therapy, which will allow a more personalised treatment for the different stages of osteoarthritis. All siNPAIN partners are working hard to develop an efficient therapy to improve the quality of life of those affected by osteoarthritis, a chronic joint condition that affects more and more people every year.
HYDROHEAL innovates with hydrogel formulations to address bone strength challenges by treating vertebral and alveolar fractures.
Last month, our colleagues Sergio Veiga and Marta Rayo represented ASPHALION at the Nabiheal Consortium Meeting, where project partners came
Last week in Siena, we joined the partners of the IMMUTOL project for its 3rd Annual Meeting
We are proud to share that the KeratoPrinter project was featured at the RAPS EuroConvergence 2026. During
Within the EU-funded ETERNAL project, where Asphalion serves as the regulatory partner, supporting the consortium to ensure
At Asphalion, we’re excited to be part of key events, conferences, and summits throughout 2026—great opportunities to connect, exchange insights, and collaborate with leaders across healthcare and medical devices.
Search or filter
Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts.
We will be happy to assist you!
